Status:
TERMINATED
Effect of Timi3 Ultrasound on Myocardial Blow Flow in the Hibernating Myocardium
Lead Sponsor:
University of California, San Francisco
Conditions:
Myocardial Ischemia
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
The purpose of this study is to evaluate whether the use application of low frequency ultrasound, administered by the Timi3 ultrasound device, increases myocardial blood flow to the heart, in subjects...
Eligibility Criteria
Inclusion
- \>/= 18 years
- Must have reversible resting ischemia, resting non-reversible blood flow defect, or stress-induced ischemia.
- Females with childbearing potential must not be pregnant at the time of the study
- Must provide written informed consent
Exclusion
- Unable or unwilling to cooperate with study procedures
- Currently enrolled in another clinical study for which the follow-up period is not complete
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT00655070
Start Date
April 1 2008
End Date
December 1 2010
Last Update
April 4 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UC San Francisco
San Francisco, California, United States, 94143